sars-cov-2 |
26 |
influenza |
24 |
humans |
20 |
covid-19 |
17 |
respiratory system - virology |
16 |
cells, cultured |
15 |
cytokines - metabolism |
15 |
mers-cov |
14 |
avian |
13 |
conjunctiva - virology |
13 |
coronavirus |
13 |
organ culture techniques |
13 |
viral tropism |
13 |
bronchi - cytology |
12 |
immunity, innate |
12 |
influenza a virus, h1n1 subtype - metabolism |
12 |
influenza, human - virology |
12 |
zoonosis |
12 |
africa |
11 |
cytokines - immunology |
11 |
transmission |
11 |
acute lung injury |
10 |
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
alveolar epithelial cells |
10 |
animals |
10 |
conjunctiva |
10 |
dead-box rna helicases - genetics - immunology - metabolism |
10 |
epithelial cells - immunology - metabolism |
10 |
h7n9 |
10 |
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
influenza a virus, h1n1 subtype - genetics - immunology |
10 |
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
influenza a virus, h5n1 subtype - genetics - immunology |
10 |
influenza a virus, h5n1 subtype - metabolism |
10 |
influenza, human - immunology - metabolism - virology |
10 |
influenza, human - metabolism - transmission |
10 |
interferon regulatory factor-3 - metabolism |
10 |
ip-10 |
10 |
janus kinases - immunology |
10 |
macrophages - immunology - metabolism |
10 |
mesenchymal stromal cells |
10 |
nf-kappa b - metabolism |
10 |
p38 mitogen-activated protein kinases - metabolism |
10 |
paracrine communication - immunology |
10 |
pulmonary alveoli - immunology - metabolism |
10 |
reassortant viruses - isolation & purification |
10 |
receptor, interferon alpha-beta - immunology |
10 |
receptors, cell surface - metabolism |
10 |
respiratory mucosa - virology |
10 |
rna, small interfering - genetics |
10 |
rna, viral - metabolism |
10 |
signal transduction |
10 |
swine |
10 |
toll-like receptor 3 - metabolism |
10 |
up-regulation |
10 |
virulence |
10 |
virus attachment |
10 |
alveolar fluid clearance |
9 |
pathogenesis |
9 |
2009 pandemic h1n1 influenza virus |
8 |
autopsy |
8 |
bronchi - immunology - pathology |
8 |
characterization |
8 |
chemokines |
8 |
china |
8 |
coronaviruses |
8 |
hong kong |
8 |
influenza a virus, h5n1 subtype - immunology |
8 |
innate host responses |
8 |
phenotype |
8 |
pulmonary alveoli - immunology |
8 |
respiratory mucosa - immunology - pathology |
8 |
swine influenza virus |
8 |
tropism |
8 |
bronchial tissue |
7 |
dna-directed dna polymerase - genetics - metabolism |
7 |
evolution |
7 |
ferrets - virology |
7 |
gene expression regulation, viral - physiology |
7 |
hemagglutinin glycoproteins, influenza virus - metabolism |
7 |
hemagglutinins - genetics - metabolism |
7 |
influenza a |
7 |
influenza a virus, h1n1 subtype - enzymology - genetics - physiology |
7 |
influenza a virus, h5n1 subtype - classification - genetics |
7 |
mers |
7 |
nasal tissue |
7 |
neuraminidase - metabolism |
7 |
omicron ba.2 |
7 |
orthomyxoviridae infections - epidemiology - transmission - virology |
7 |
pathogenicity |
7 |
sars |
7 |
viral genes |
7 |
airway epithelial cells |
6 |
cigarette smoking |
6 |
cytokine |
6 |
dogs |
6 |
ex vivo |
6 |
explants |
6 |
hpai |
6 |
immunocompromised host - immunology |
6 |
influenza a virus |
6 |
influenza a virus, h1n1 subtype - physiology |
6 |
influenza, human - immunology |
6 |
nsp6 |
6 |
pulmonary alveoli - immunology - virology |
6 |
risk assessment |
6 |
sars-cov |
6 |
virus evolution |
6 |
adaptation, biological |
5 |
antiviral agents - pharmacology |
5 |
cell polarity |
5 |
clade 2.3.4.4 |
5 |
cyclosporine |
5 |
emetine |
5 |
endothelial cells - immunology - virology |
5 |
epithelial cells - immunology - virology |
5 |
ex vivo explants |
5 |
fomite |
5 |
hpai h5nx |
5 |
indirubin |
5 |
influenza a virus - enzymology - genetics |
5 |
influenza a virus - genetics - metabolism - physiology |
5 |
influenza a virus, h1n1 subtype - immunology - pathogenicity |
5 |
influenza a virus, h5n1 subtype - drug effects |
5 |
influenza a virus, h9n2 subtype - genetics - pathogenicity |
5 |
influenza in birds - enzymology |
5 |
influenza, human - prevention and control - virology |
5 |
interferons - metabolism - pharmacology |
5 |
lopinavir |
5 |
lung - cytology - drug effects - virology |
5 |
lung - drug effects - metabolism - virology |
5 |
macrophages |
5 |
mammals - virology |
5 |
middle east respiratory syndrome coronavirus (mers-cov) |
5 |
pneumocytes |
5 |
recombinant fusion proteins - pharmacology |
5 |
remdesivir |
5 |
ritonavir |
5 |
rna replicase - genetics - metabolism |
5 |
signal transduction - physiology |
5 |
tissue tropism |
5 |
type i interferon |
5 |
viral nonstructural proteins - genetics - metabolism - physiology |
5 |
viral proteins - genetics - metabolism |
5 |
virulence factors - genetics - metabolism |
5 |
adolescent |
4 |
antiviral agents - pharmacokinetics - pharmacology |
4 |
apoptosis |
4 |
avian influenza h5n1 virus |
4 |
bronchial epithelial cells |
4 |
cell cycle |
4 |
cell cycle arrest |
4 |
cell function |
4 |
cell isolation |
4 |
cell migration |
4 |
child |
4 |
coronavirus disease 2019 |
4 |
cyclin d3 |
4 |
epithelium - virology |
4 |
ex vivo bronchi |
4 |
eye tissue |
4 |
farnesyl transferase inhibitor |
4 |
fludase |
4 |
g1/s cyclin |
4 |
h5n1 |
4 |
h5n1 influenza virus |
4 |
hae |
4 |
host response |
4 |
human |
4 |
human respiratory epithelial cell in vitro cultures |
4 |
human respiratory organ ex vivo cultures |
4 |
immunohistochemistry |
4 |
immunology |
4 |
influenza a virus, h1n1 subtype - pathogenicity - physiology |
4 |
influenza a virus, h5n1 subtype - pathogenicity - physiology |
4 |
influenza virus vaccines |
4 |
influenza, human - prevention & control |
4 |
live vector vaccines |
4 |
m2 |
4 |
maackia amurensis agglutinin |
4 |
medical sciences |
4 |
orthomyxoviridae - drug effects |
4 |
protein degradation |
4 |
protein-protein interaction |
4 |
recombinant fusion proteins - pharmacokinetics - pharmacology |
4 |
respiratory mucosa - cytology - metabolism - virology |
4 |
restriction factor |
4 |
sambucus nigra agglutnin |
4 |
sciences: comprehensive works |
4 |
sialic acid receptors |
4 |
statin |
4 |
sterol biosynthesis |
4 |
type ii pneumocytes |
4 |
type-i-like pneumocytes |
4 |
universal vaccine |
4 |
zometa |
4 |
airway epithelium cell |
3 |
animal cell |
3 |
animal experiment |
3 |
animal model |
3 |
antiviral susceptibility |
3 |
apoptosis - drug effects |
3 |
avian h5n1 virus |
3 |
bronchi - metabolism |
3 |
cell survival - drug effects |
3 |
chemokine cxcl10 - metabolism |
3 |
cytoprotection |
3 |
endothelial cell |
3 |
enzyme-linked immunosorbent assay |
3 |
ex vivo human bronchus culture |
3 |
ex vivo lung culture |
3 |
flow cytometry |
3 |
ginsenoside |
3 |
ginsenosides - pharmacology |
3 |
human seasonal h1n1 virus |
3 |
human umbilical vein endothelial cells - drug effects - immunology - pathology - virology |
3 |
immunologic factors - pharmacology |
3 |
in situ nick-end labeling |
3 |
inflammation mediators - metabolism |
3 |
influenza a virus, h1n1 subtype - pathogenicity |
3 |
influenza a virus, h9n2 subtype - pathogenicity |
3 |
ip-11 |
3 |
micrornas - metabolism |
3 |
microvascular endothelial cells |
3 |
mir-15b |
3 |
models, biological |
3 |
neuraminidase - chemistry |
3 |
pandemic h1n1pdm virus |
3 |
real-time polymerase chain reaction |
3 |
recombinant fusion proteins - chemistry - pharmacology |
3 |
sapogenins - pharmacology |
3 |
sars virus - pathogenicity |
3 |
severe acute respiratory syndrome - virology |
3 |
tissue culture techniques |
3 |
transfection |
3 |
intercellular signaling peptides and proteins |
2 |
neural cell adhesion molecules - metabolism |
2 |
proteins - genetics - metabolism |
2 |
receptor protein-tyrosine kinases - genetics - metabolism |
2 |
sertoli cells |
2 |
testicular cell lines |
2 |
testis - cytology - enzymology - metabolism |
2 |
tyrosine phosphorylation |
2 |
epidermal growth factor |
1 |
h1n1 |
1 |
inflammation |
1 |
resilience |
1 |
tolerance |
1 |